SDAIA Showcases Data and AI Initiatives at Riyadh Biotech Summit

The Saudi Data and AI Authority (SDAIA) is showcasing its key national efforts and initiatives in data and artificial intelligence at its pavilion during the fourth Riyadh Global Medical Biotechnology Summit 2026 (RGMBS), held in Riyadh from September 14 to 16. The participation underscores Saudi Arabia’s commitment to advancing a data- and AI-driven economy in line with Vision 2030.

Context and Background

The Riyadh Global Medical Biotechnology Summit is a leading international event that brings together experts, researchers, and industry leaders to discuss the latest developments in medical biotechnology. SDAIA’s presence at the summit highlights the authority’s role in building an advanced national ecosystem for data and AI, and its efforts to support innovation and strengthen integration with relevant entities.

As the national authority responsible for data and AI, SDAIA is tasked with driving the Kingdom’s transition toward a knowledge-based economy. Its participation in RGMBS 2026 reflects the growing intersection of data science, AI, and biotechnology, and the potential for these fields to contribute to improved healthcare outcomes and economic diversification.

Key Details

At its pavilion, SDAIA is introducing visitors to the SDAIA Data Regulatory Sandbox, an initiative that enables innovation and the development of data-driven solutions in a flexible and secure regulatory environment. The sandbox helps develop data-related regulatory practices and frameworks, including those related to biotechnology.

The pavilion also showcases integrated digital services provided through the national super app Tawakkalna, which has become an essential tool for millions of users in Saudi Arabia. Additionally, SDAIA is featuring several specialized publications that aim to raise awareness of data governance and promote responsible use of data and AI.

These displays give RGMBS visitors an overview of SDAIA’s efforts to support innovation, foster collaboration, and contribute to the objectives of Saudi Vision 2030.

Implications and Impact

SDAIA’s participation in the fourth Riyadh Global Medical Biotechnology Summit demonstrates the Kingdom’s leadership in leveraging advanced technologies for the benefit of society. By showcasing its initiatives, SDAIA is positioning Saudi Arabia as a hub for innovation in data and AI, with applications that extend to healthcare, biotechnology, and beyond.

The event also provides a platform for knowledge exchange and partnership building, which can accelerate the development of solutions that address global challenges. This aligns with Saudi Arabia’s broader efforts to diversify its economy and enhance its global competitiveness.

Vision 2030 Alignment

SDAIA’s initiatives are directly aligned with Saudi Vision 2030, which seeks to transform the Kingdom into a diversified, innovation-driven economy. By fostering a robust data and AI ecosystem, SDAIA is helping to create new opportunities for growth, improve public services, and enhance the quality of life for citizens and residents. The authority’s work at the Riyadh Global Medical Biotechnology Summit exemplifies how Saudi Arabia is harnessing technology to build a brighter future and contribute to global progress.

20 Questions

Q1. What is SDAIA showcasing at the fourth Riyadh Global Medical Biotechnology Summit?

A1. SDAIA is showcasing its key national efforts and initiatives in data and artificial intelligence, including the Data Regulatory Sandbox and Tawakkalna services, at its pavilion during the summit.

Q2. Where and when is the fourth Riyadh Global Medical Biotechnology Summit taking place?

A2. The summit is being held in Riyadh, Saudi Arabia, from September 14 to 16, 2026, bringing together experts and leaders in medical biotechnology.

Q3. What is the SDAIA Data Regulatory Sandbox?

A3. The SDAIA Data Regulatory Sandbox is an initiative that enables innovation and develops data-driven solutions in a flexible and secure regulatory environment, including for biotechnology.

Q4. How does the sandbox support biotechnology?

A4. The sandbox helps develop data-related regulatory practices and frameworks, including those related to biotechnology, fostering innovation while ensuring compliance and security.

Q5. What is Tawakkalna and what does it offer?

A5. Tawakkalna is Saudi Arabia’s national super app, providing integrated digital services to millions of users, and it is being showcased at the SDAIA pavilion.

Q6. What publications is SDAIA featuring at the summit?

A6. SDAIA is featuring several specialized publications that help raise awareness of data governance and promote responsible use of data and AI.

Q7. What is the purpose of SDAIA’s participation in the summit?

A7. SDAIA aims to highlight its role in building an advanced national ecosystem for data and AI, support innovation, and strengthen integration with relevant entities.

Q8. How does SDAIA’s work align with Saudi Vision 2030?

A8. SDAIA’s efforts support the transition toward a data- and AI-driven economy, contributing directly to the objectives of Saudi Vision 2030 for economic diversification and innovation.

Q9. Who is leading SDAIA’s efforts in data and AI?

A9. SDAIA, as the national authority, leads Saudi Arabia’s data and AI initiatives, under the guidance of the Kingdom’s leadership to advance Vision 2030.

Q10. What are the key benefits of the Data Regulatory Sandbox?

A10. The sandbox provides a secure environment for testing and developing data-driven solutions, helping to create regulatory frameworks that support innovation in sectors like biotechnology.

Q11. How does Tawakkalna contribute to Saudi Arabia’s digital transformation?

A11. Tawakkalna offers integrated digital services that enhance user convenience and support the Kingdom’s digital transformation goals under Vision 2030.

Q12. What types of entities are participating in the summit?

A12. The summit brings together experts, researchers, and industry leaders from around the world to discuss advancements in medical biotechnology and related fields.

Q13. What role does data governance play in SDAIA’s initiatives?

A13. Data governance is central to SDAIA’s work, ensuring responsible use of data and AI while fostering innovation and building trust in digital technologies.

Q14. How can the sandbox accelerate innovation in biotechnology?

A14. By providing a flexible regulatory environment, the sandbox allows innovators to test solutions quickly and safely, accelerating the development of biotech applications.

Q15. What are the broader implications of SDAIA’s participation for Saudi Arabia?

A15. It reinforces Saudi Arabia’s position as a leader in data and AI, attracts global partnerships, and supports economic diversification and knowledge transfer.

Q16. How does SDAIA support integration with other entities?

A16. SDAIA collaborates with government, private sector, and academic partners to strengthen the national data and AI ecosystem and achieve shared goals.

Q17. What is the significance of the summit for global medical biotechnology?

A17. The summit serves as a platform for international collaboration, knowledge exchange, and showcasing innovations that can improve healthcare worldwide.

Q18. How does SDAIA promote responsible AI use?

A18. Through publications, awareness campaigns, and regulatory frameworks, SDAIA promotes ethical and responsible use of AI and data across all sectors.

Q19. What can visitors expect at the SDAIA pavilion?

A19. Visitors can learn about the Data Regulatory Sandbox, Tawakkalna services, and SDAIA’s publications, gaining insight into Saudi Arabia’s data and AI advancements.

Q20. How does SDAIA’s work contribute to Saudi Arabia’s global role?

A20. SDAIA’s initiatives position Saudi Arabia as a global hub for data and AI innovation, enhancing the Kingdom’s influence and contributing to global progress.

---